Clinical Trials · NCT00079001

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Name: Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Gonadorelin

Phase: Phase 3
Recruitment status: Completed
Sponsor: Alliance for Clinical Trials in Oncology
Enrollment: 645
Start date: Jan 2004
Locations: 241 sites, United States, Canada
Primary endpoint: Time to First Skeletal Related Event

View Gonadorelin compound reference